EU Advocate General Recommends Annulling Pharmaceutical Wastewater Treatment Cost Requirement
Source Summary
An EU Advocate General has recommended annulling a portion of an EU directive that requires pharmaceutical manufacturers to finance 80% of wastewater treatment costs. The recommendation, if adopted, would reduce the financial burden on drugmakers for environmental compliance in Europe.
Why it matters
This recommendation could significantly reduce regulatory compliance costs for pharmaceutical companies operating in the EU.
What remains uncertain
It is unclear whether the EU Court will adopt the Advocate General's recommendation.
